References
- Agid Y., Javoy F., Glowinski J. Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat. Nature 1973; 245: 150–151
- Algeri S., Brunello N., Calderini G., Consolazione A. Effect of enkephalins on catecholamine metabolism in rat CNS. Advances in biochemical psychopharmacology, E. Costa, M. Trabucchi. Raven press, New York 1978; Vol. 18: 199–210
- Bernheimer H., Birkmayer W., Hornykiewicz O. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. Journal of Neurological Sciences 1973; 20: 415–455
- Bokobza B., Ruberg M., Scatton M., Javoy-Agid F., Agid Y. 3H-spiperone binding dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. European Journal of Pharmacology 1984; 99: 167–175, 1984
- Costa E., Carenzi A., Guidotti A. Narcotic analgesics and the regulation of neuronal catecholamine stores. Frontiers in catecholamine research, E. Usdin, S. H. Snyder. Pergamon Press, London 1973; 1003–1010
- Diamond B. I., Borison R. L. Enkephalins and nigrostriatal function. Neurology 1978; 28: 1085–1088
- Drucker-Colin R., Madrazo I., Shkurovich M., Ostrosky-Solis F., Torres C. Open microsurgical autograft of adrenal medulla to caudate nucleus of patients with Parkinson's disease. Schmitt Neurological Sciences Symposium. Rochester, New York, (abstract).
- Hokfelt T., Elde R., Johansson O. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system. Neuroscience Letters 1977; 5: 25–31
- Hornykiewicz O. Dopamine and brain function. Pharmacological Review 1966; 18: 925–964
- Iacono R. P., Sandyk R. Opioid mechanisms in the therapeutic efficacy of adrenal medullary tissue transplantation in Parkinson's disease. Journal of Neurosurgery 1988; 68: 158–159
- Javoy-Agid F., Ruberg M., Pique L., Bertagna X., Taquet H., Studler J. M., Cesselin F., Epelbaum J., Agid Y. Biochemistry of the hypothalamus in Parkinson's disease. Neurology 1984; 34: 672–675
- Kizer J. S., Palkovits M., Brownstein M. J. The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigro-hypothalamic-median eminence dopaminergic pathway. Brain Research 1976; 108: 363–370
- Langston J. W., Forno L. S. The hypothalamus in Parkinson's disease. Annals of Neurology 1978; 3: 129–133
- Nappi G., Petraglia F., Martignoni E., Facchinetti F., Bono G., Genazzani A. R. Beta-endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology 1985; 35: 1371–1374
- Nauta W. J. H., Haymaker W. Hypothalamic nuclei and fiber connections, W. Haymaker, E. Anderson, W. J. H. Nauta. Illinois, Springfield 1969; 136–208
- Pezzoli G., Panerai A E., Di Giulio A., Longo A., Passerini D., Carenzi A. Methionine enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients. Neurology 1984; 34: 516–519
- Pollard H., Llorens C., Schwartz J. C, Gros C., Dray F. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Brain Research 1978; 151: 392–398
- Pollard H., Llorens-Cortes C., Schwartz J. C. Enkephalin receptors on dopaminergic neurons in rat striatum. Nature 1977; 268: 745–747
- Sandyk R. The endogenous opioid system in neurological disorders of the basal ganglia. Life Sciences 1985; 37: 1655–1663
- Sandyk R. Sensory symptoms in Parkinson's disease. Pain 1986; 25: 139–140
- Taquet H., Javoy-Agid F., Cesselin F., Agid Y. Methionine-enkephalin deficiency in brains of patients with Parkinson's disease. Lancet 1981; 2: 1367–1368
- Walczak S. A., Wilkening D., Markman M. H. Interaction of morphine, etorphine and enkephalins with dopamine-stimulated adenylate cyclase of monkey amygdala. Brain Research 1979; 160: 105–116
- Zigmond M. J., Acheson A. L., Stachowiak M. K., Strickerm E. M. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Archives of Neurology 1984; 41: 856–861